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Abstract The unicellular green alga Chlamydomonas
reinhardtii has become an invaluable model system in
plant biology. There is also considerable interest in
developing this microalga into an efficient production
platform for biofuels, pharmaceuticals, green chemicals
and industrial enzymes. However, the production of foreign
proteins in the nucleocytosolic compartment of Chlamy-
domonas is greatly hampered by the inefficiency of trans-
gene expression from the nuclear genome. We have
recently addressed this limitation by isolating mutant algal
strains that permit high-level transgene expression and by
determining the contributions of GC content and codon
usage to gene expression efficiency. Here we have applied
these new tools and explored the potential of Chlamy-
domonas to produce a recombinant biopharmaceutical, the
HIV antigen P24. We show that a codon-optimized P24
gene variant introduced into our algal expression strains
give rise to recombinant protein accumulation levels of up
to 0.25 % of the total cellular protein. Moreover, in com-
bination with an expression strain, a resynthesized nptII
gene becomes a highly efficient selectable marker gene that
facilitates the selection of transgenic algal clones at high
frequency. By establishing simple principles of successful
transgene expression, our data open up new possibilities for
biotechnological research in Chlamydomonas.
Keywords Chlamydomonas reinhardtii  Molecular
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Introduction
The unicellular green alga Chlamydomonas reinhardtii is
widely used as a model organism for research on funda-
mental questions in cell and molecular biology, including
chloroplast biology, photosynthesis, light perception and
signaling as well as flagellar function and tactic movements
(Harris 2001; Merchant et al. 2007). In its vegetative phase,
Chlamydomonas is a haploid organism and can be grown
photoautotrophically, mixotrophically or heterotrophically
(using acetate as the sole source of organic carbon; Harris
1989). Triggered by environmental cues, two vegetative
cells of opposite mating types (mt? and mt-) can differ-
entiate into gametes and engage in sexual reproduction. All
three genomes of the alga (in the nucleus, the plastid and
the mitochondria) are completely sequenced (Merchant
et al. 2007) and can be stably transformed (Kindle et al.
1991; Remacle et al. 2006; Neupert et al. 2012).
The ease with which Chlamydomonas can be cultured in
large volumes and the ease with which it can be genetically
engineered have also made the alga a preferred model
organism in biotechnological research, especially for
metabolic engineering, biofuel production and the synthe-
sis of proteinaceous biopharmaceuticals and industrial
enzymes, an area commonly referred to as molecular
farming (Scaife et al. 2015; Scranton et al. 2015). How-
ever, harnessing the full potential of Chlamydomonas in
biotechnology turned out to be challenging because of
severe problems with (i) the expression of nuclear trans-
genes to reasonable levels (Fuhrmann et al. 1999; Schroda
et al. 2000), and (ii) epigenetic transgene inactivation
mechanisms that cause loss of expression with time (Ya-
masaki et al. 2008). Although introduction of transgenes
into the nuclear genome of the alga is straightforward, the
isolation of transgenic strains that express the foreign gene
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of interest to detectable levels, in many cases, has turned
out to present an unsurmountable challenge (Mussgnug
2015). Identification of promoters suitable to drive strong
transcription of heterologous genes (Fischer and Rochaix
2001), construction of hybrid promoters (Schroda et al.
2000) and resynthesis of the coding region of the transgene
to adjust its codon usage to that of the Chlamydomonas
nuclear genome (Fuhrmann et al. 1999, 2004; Shao and
Bock 2008), has led to some improvements, but did not
provide a general solution to the transgene expression
problem. Recently, we described a genetic screen that
facilitates the selection of mutant algal strains that express
introduced reporter genes to high levels (Neupert et al.
2009). Two mutant strains (UVM4 and UVM11) were
isolated from a UV mutagenesis experiment (Neupert et al.
2009) and have quickly become widely used as versatile
tools for transgene expression and subcellular localization
analyses (e.g., Karcher et al. 2009; Za¨uner et al. 2012;
Bohne et al. 2013; Lauersen et al. 2013, 2015; reviewed,
e.g., in Jinkerson and Jonikas 2015).
In addition to promoter choice and the genetic consti-
tution of the recipient strain, the efficiency of transgene
expression is influenced by the properties of the coding
region. The Chlamydomonas nuclear genome has an
unusually high GC content (Merchant et al. 2007) and
genes with low GC content or strongly deviating codon
usage are known to be expressed only very poorly or not at
all (Fuhrmann et al. 1999; Shao and Bock 2008; Bar-
ahimipour et al. 2015). Although GC content and codon
usage are connected (in that both are influenced by selec-
tive pressure on nucleotide composition of the genome),
their relative contributions to expression efficiency are
experimentally separable. Expressing YFP gene variants
that differ in GC content and/or codon usage, we have
recently demonstrated that codon usage, rather than GC
content, is the most important determinant of transgene
expression efficiency in Chlamydomonas reinhardtii
(Barahimipour et al. 2015). Together with the availability
of strong promoters (Schroda et al. 2000; Fischer and
Rochaix 2001) and algal expression strains that permit
high-level transgene expression (Neupert et al. 2009;
Karcher et al. 2009), this finding raises hopes that we now
have the most important tools required to optimize foreign
gene expression in Chlamydomonas and elevate it to levels
that are comparable to other systems (such as yeasts and
seed plants). This would make the alga competitive with
other production platforms in biotechnology and open up
new possibilities for its commercial use.
Here, we have applied the knowledge gained about
nuclear transgene expression and explored the potential of
Chlamydomonas for the expression of two biotechnologi-
cally relevant genes: the gene for the HIV-1 antigen P24, a
likely indispensable component of any future AIDS
vaccine, and the kanamycin resistance gene nptII, a widely
used selectable marker gene that, however, does not work
well for Chlamydomonas (Hall et al. 1993; Bingham et al.
1989). Originally isolated from the Escherichia coli
transposon Tn5, it has quickly become widely used as a
selectable marker for transformation experiments in both
prokaryotes and eukaryotes. It also represents the by far
most frequently used marker for nuclear transformation in
seed plants and also works as a selectable marker for
chloroplast transformation in tobacco (Nicotiana tabacum;
Elghabi et al. 2011; Carrer et al. 1993). However, attempts
to develop nptII as a marker for nuclear transformation in
Chlamydomonas have remained largely fruitless. Although
introduction of nptII as a passenger gene along with a
different selectable marker (nitrate reductase; Hall et al.
1993) resulted in clones that displayed low-level kanamy-
cin resistance, direct selection for kanamycin resistance
was largely unsuccessful and, in one published study,
produced only a single exceptional transformation event
(Bingham et al. 1989).
Since the beginning of the acquired immune deficiency
syndrome (AIDS) epidemic, 78 million people worldwide
have been infected with the human immunodeficiency virus
(HIV, mainly with variant HIV-1) and 39 million people
have died of the disease (http://www.who.int/gho/hiv/en/).
Globally, approximately 35 million people were living with
the virus in 2013, and a large number of these infections are
located in developing countries. A safe, effective and
affordable vaccine that reduces transmission of HIV-1 or,
alternatively, prevents disease progression is desperately
needed. Unfortunately, despite more than 30 years of
intense research efforts, there is still no effective AIDS
vaccine on the horizon. The complex biology of the infec-
tion process and the high mutation rate of the virus (Trkola
2004) make it likely that a multi-component vaccine com-
prising several antigenic polypeptides of HIV-1 will be
required to invoke broad and potent immunity. Provided
that suitable candidate antigens for recombinant subunit
vaccines can be identified, crop plants or edible algae (such
as Chlamydomonas reinhardtii) would provide the ideal
production platform to cheaply produce large quantities of
an AIDS vaccine that can be administered orally and is
stable even without an uninterrupted cooling chain.
The HIV-1 protein P24 (or p24) forms the conical core
of HIV-1 viral particles. P24 represents the largest cleavage
product of the precursor polyprotein encoded by the gag
gene of the retrovirus. P24 is the target of T cell immune
responses in both primary infected and chronically infected
AIDS patients. Also, capsid proteins, such as P24, are
preferred candidates for vaccine components, because of
their high conservation due to structural and functional
constraints, thus facilitating the targeting of specific epi-
topes that lie within conserved domains of the viral
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particle. As P24 is expected to be a crucial component of
any future AIDS vaccine (Obregon et al. 2006), enormous
efforts have been undertaken to develop expression
strategies for the high-yield and cost-effective production
of recombinant P24 protein (Meyers et al. 2008). Proof-of-
concept studies in tobacco have shown that the protein can
be expressed from the nuclear genome of plants (Zhang
et al. 2002; Obregon et al. 2006) and, much more effi-
ciently, from the plastid genome (Zhou et al. 2008;
McCabe et al. 2008; Shanmugabalaji et al. 2013). Impor-
tantly, several immunogenicity studies with tobacco-
derived P24 protein demonstrated elicitation of T cell
responses in experimental animals (e.g., Meyers et al.
2008; Gonzalez-Rabade et al. 2011).
In this study, we have compared P24 and nptII gene
variants that encode the identical amino acid sequence but
differ in codon usage, and tested them in our expression
strain UVM11 and a wild type-like strain of Chlamy-
domonas reinhardtii. We demonstrate that fully codon
optimized gene versions introduced into our algal expres-
sion strains allow high-level expression of the P24 antigen
and turn the nptII gene into an efficient selectable marker
gene for Chlamydomonas. Our work reported here estab-
lishes straightforward rules for successful transgene
expression in Chlamydomonas, and opens up new appli-
cations in algal biotechnology.
Materials and methods
Algal strains and culture conditions
The Chlamydomonas reinhardtii cell wall-deficient strains
Elow47 and UVM11 (Neupert et al. 2009) were used for all
transformation experiments. Both strains are derived from the
arginine auxotrophic strain cw15–302 (cwdmt? arg7). Strain
Elow47 was generated by co-transformation of cw15–302
with the CRY1–1 emetine resistance gene and the ARG7 gene
providing arginine prototrophy. Strain UVM11 was obtained
by UVmutagenesis of Elow47 followed by selection for high
transgene expression (Neupert et al. 2009). Algal cells were
cultivated mixotrophically in liquid Tris-acetate-phosphate
(TAP) medium (Harris, 1989) or on agar-solidified TAP
medium at 22 C under continuous illumination (light
intensity: 50–100 lE m-2 s-1), unless otherwise stated.
Construction of transformation vectors
Three gene variants of P24 (encoding the conical core
subunit of HIV-1 viral particles) that differ in their GC
content and codon usage were generated as follows: NdeI
and EcoRI recognition sequences containing a start codon
and a stop codon, respectively, were introduced upstream
and downstream of the coding regions of all P24 gene
variants. Variant P24w is identical to the wild-type P24
sequence (nucleotides 508–1200 of HIV-1, isolate BH10,
Gene Bank accession number: M15654.1). Variant CrP24
was codon optimized for the nuclear genome of Chlamy-
domonas (using the codon frequency table of the Kazusa
database: http://www.kazusa.or.jp/codon/) and chemically
synthesized (GeneCust). Both versions were cloned as
NdeI/EcoRI restriction fragments into pJR38 (Neupert
et al. 2009) digested with the same enzymes, giving rise to
plasmids pRMB18 and pRMB19, respectively. CpP24, an
AT-rich lowly codon-adapted variant (codon optimized for
the tobacco chloroplast genome) was amplified from
plastid transformation vector pZF1 (Zhou et al. 2008) using
primers CpP24NdeIf (50-AAGCCCATATGCCTATTGTAC
AAAATATTCAAGG-30) and CpP24EcoRIr (50-TGCCA
GAATTCTTAGAGTACTCTAGCTTTATG-30; restriction
sites underlined, start and stop codons indicated in bold). The
PCR amplicon was cloned into the pCR2.1-TOPO TA
vector and, after sequence confirmation, the CpP24 gene was
excised as NdeI/EcoRI restriction fragment and ligated into
the similarly digested plasmid pJR38, generating transfor-
mation vector pRMB20.
Two gene variants of neomycin phosphotransferase II
gene nptII, EcnptII and CrnptII, with identical amino acid
sequence but different GC content and codon usage were
analyzed. The AT-rich EcnptII sequence (originally from
E. coli transposon Tn5) was amplified from plastid trans-
formation vector pRB96 (Wurbs et al. 2007) using primers
NptIINdeIf (50-CAAGCCCATATGGAACAAGATGGAT
TG-30) and NptIIEcoRIr (50-AGAATTCTTAGAAGAAC
TCGTCAAGAAGGCG-30; restriction sites underlined,
start and stop codons indicated in bold) that introduce NdeI
and EcoRI restriction sites at the 50 and 30 ends of the gene,
respectively. The PCR product was cloned into vector
pCR2.1-TOPO TA (Invitrogen). After sequence confir-
mation, the NdeI/EcoRI restriction fragment was cloned
into the similarly digested plasmid pJR38 (Neupert et al.
2009), resulting in transformation vector pRMB28. The
gene sequence of the CrnptII variant was codon optimized
according to the preferred codon usage in the Chlamy-
domonas nuclear genome using the codon frequency
table of the Kazusa database (http://www.kazusa.or.jp/
codon/) and then chemically synthesized (GeneCust,
Dudelange, Luxembourg). Unique NdeI and EcoRI
restriction sites at the 50 and 30 ends of the gene, respec-
tively, were used for cloning into the similarly digested
plasmid pJR38, generating transformation vector pRMB27.
Transformation of Chlamydomonas reinhardtii
Nuclear transformation of the Elow47 and UVM11 strains
of Chlamydomonas reinhardtii was performed using the
Plant Mol Biol (2016) 90:403–418 405
123
glass bead method and following published protocols
(Kindle 1990; Neupert et al. 2012). 1 lg of plasmid DNA
linearized with ScaI or NaeI was used for transformation of
the P24 variants into the algal genome. Transformants were
selected on TAP medium containing 10 lg mL-1 paro-
momycin. Transformation with the nptII gene variants was
performed with 250 ng of gel-eluted (NucleoSpin Gel and
PCR Clean-up kit, Macherey–Nagel, Du¨ren, Germany)
XhoI/XbaI restriction fragment containing the nptII coding
region and the PSAD promoter and terminator sequences.
The aphVIII cassette under the control of the HSP70/
RBCS2 promoter was eluted after digestion of pJR38 with
restriction enzymes KpnI and XhoI. Transformants were
selected on TAP medium supplemented with
25–200 lg mL-1 kanamycin.
DNA isolation, Southern blot analysis and PCR
Total genomic DNA from Chlamydomonas was extracted
according to published protocols (Schroda et al. 2001).
100 ng DNA were used as template for PCR assays and
10 lg were used for Southern blot analyses.
To identify transformants that have the complete P24
transformation cassette integrated into their nuclear gen-
ome (i.e., the selectable marker gene and the entire trans-
gene of interest), PCR assays were conducted using primer
pairs that amplify sequences upstream and downstream of
the gene of interest. Primers PPsaDrev (50 CGAGCCCTT
CGAACAGCCAGGCCG 30) and M13for (50 GTAAAAC
GACGGCCAGT 30) amplified the 50 end of the PsaD
promoter upstream of the coding region of the transgene of
interest (380 bp amplicon), and primers APHVIII.rev (50
CCTCAGAAGAACTCGTCCAACAGCC 30) and APH-
VIII.fw (50 GGAGGATCTGGACGAGGAGCGGAAG 30)
amplified the 30 end of the aphVIII selectable marker gene
(360 bp amplicon). Transformed algal strains yielding both
PCR products were selected as positive clones.
For Southern blot analysis, samples of 10 lg DNA were
digested with the appropriate restriction enzymes, sepa-
rated in a 1 % agarose gel, and transferred onto a
HybondTM N? nylon membrane (GE Healthcare) by cap-
illary blotting. An [a-32P]dCTP-labeled probe was pro-
duced by random priming (MegaprimeTM DNA labeling
system, GE Healthcare) using the complete open reading
frame of CrP24 as template. Hybridization took place at
65 C according to standard protocols.
RNA extraction and northern blot analysis
Total RNA was isolated from algal cultures using the
Direct-ZolTM RNA MiniPrep kit (Zymo Research) and
following the manufacturer’s protocol. Samples of 10 lg
RNA were separated in 1.2 % agarose gels containing 2 %
formaldehyde and then transferred onto HybondTM N?
nylon membranes (GE Healthcare) by capillary blotting.
Hybridization was performed at 65 C using [a-32P]dCTP-
labeled probes (GE Healthcare) that were produced by
random priming (MegaprimeTM DNA labeling system, GE
Healthcare). Restriction fragments covering the entire
reading frame of the transgene were excised with NdeI and
EcoRI from the corresponding transformation vectors and
used as templates for probe generation. A 1:1 mixture of
CrnptII and EcnptII fragments was used to produce a probe
capable of detecting both transcripts with equal sensitivity.
Protein extraction and immunoblot analyses
Total protein was extracted using a phenol-based extraction
method (Cahoon et al. 1992). Extraction was performed by
resuspension of the cell pellet in extraction buffer [0.7 M
sucrose, 0.5 M Tris/HCl, 50 mM EDTA, 0.1 M KCl pH
9.4, 2 % 2-mercaptoethanol and 19 protease inhibitor
cocktail cOmplete, EDTA-free (Roche, Darmstadt, Ger-
many)]. An equal volume of phenol (Roti-Phenol, Roth,
Germany) was added, the sample was mixed thoroughly
and centrifuged at 15,0009g for 10 min at 4 C. The
supernatant was transferred to a new tube and mixed with
five volumes of 0.1 M NH4OAc in methanol. Proteins were
precipitated overnight at -20 C, and pelleted by cen-
trifugation at 15,0009g and 4 C for 5 min. Pellets were
washed with 0.1 M NH4OAc in methanol, air-dried and
resuspended in 1 % SDS at 60 C for 3 min. Protein con-
centration of the extracts was determined with the BCA
assay kit (Pierce, Rockford, IL,USA). Samples of 40 lg
protein were separated by electrophoresis in 15 % SDS-
PAA gels and subsequently transferred onto PVDF mem-
branes (GE Healthcare, UK) using a standard transfer
buffer (192 mM glycine, 25 mM Tris/HCl, pH 8.3).
Blocking was performed with either 5 % BSA for detection
of P24, or 2.5 % BSA and 2.5 % milk powder for detection
of the NptII protein at room temperature for 1 h. Immun-
odetection of NptII was done with a 1:1000 dilution of
rabbit anti-NptII primary antibody (Sigma) and a 1:50,000
dilution of anti-rabbit HRP-conjugated secondary antibody
(Agrisera). The P24 protein was detected with a 1:1000
dilution of a monoclonal mouse anti-P24 primary antibody
(Abcam) and a 1:5000 dilution of anti-mouse HRP-conju-
gated antibody (Agrisera). Hybridization signals were
visualized by the ECLTM Prime detection system (GE
Healthcare).
Antibiotic resistance tests
To compare the phenotypic resistance of aphVIII and
CrnptII transformants to different antibiotics, nine inde-
pendently transformed clones per transgene (initially
406 Plant Mol Biol (2016) 90:403–418
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selected on TAP medium containing 25 lg mL-1 kana-
mycin) were randomly chosen and maintained on agar-
solidified TAP medium without antibiotics. Cultures grown
in antibiotic-free liquid TAP medium were used for drop
tests on agar-solidified TAP medium containing either
2.5–25 lg mL-1 G418 (G418 disulphate salt solution,
Sigma-Aldrich), 5–50 lg mL-1 paromomycin (paro-
momycin sulphate, Duchefa Biochemie B.V.) or
25-200 lg mL-1 kanamycin (kanamycin monosulphate
monohydrate, Duchefa Biochemie B.V.) under constant
light of 50 lE m-2 s-1. To determine the level of resis-
tance of EcnptII and CrnptII transformants to different
concentrations of kanamycin (0–200 lg mL-1), additional
drop tests were performed with dilution series of cultures
of the 10 independent transformed strains (initially selected
on 50 lg mL-1 kanamycin) that had been characterized by
northern blot and immunoblot analyses.
Results
Design of P24 gene variants for expression
in Chlamydomonas
To identify factors involved in expression of the HIV
antigen P24 in Chlamydomonas reinhardtii, we synthesized
three variants of the P24 gene that encode the identical
amino acid sequence but differ in codon usage and GC
content (Fig. 1a, b; Table 1): (i) the wild-type sequence
from HIV-1 subsequently referred to us P24w, (ii) a ver-
sion with the codon usage optimized for the AT-rich
chloroplast genome (CpP24), and (iii) a version with the
codon usage optimized for the GC-rich nuclear genome of
Chlamydomonas (CrP24). Comparing codon usage and GC
content, the CpP24 gene variant is expected to have the
most unfavorable gene sequence for expression from the
nuclear genome of Chlamydomonas, whereas the wild-type
variant P24w has more triplets that are frequently used in
Chlamydomonas and also a higher GC content than CpP24
(Fig. 1a, b). The three gene versions were cloned into the
same expression cassette, inserted into the same transfor-
mation vector (Fig. 1c) and transformed into two different
strains of Chlamydomonas by glass bead-assisted DNA
delivery: the expression strain UVM11 isolated from a UV
mutagenesis-based genetic screen for algal strains with
improved expression properties, and the wild type-like
control strain Elow47 (Neupert et al. 2009). This resulted
in altogether six sets of transgenic algal clones that were
compared with each other with respect to their efficiency of
expressing the P24 antigen.
mRNA and protein accumulation from the different
gene variants in wild type-like stains and expression
strains
From each of the six transformation experiments, 24 clones
were randomly picked and integration of the P24 expres-
sion cassette was verified by PCR assays (Fig. 1c; see
‘‘Materials and methods’’ section). On average, 58 % of the
UVM11 transformants and 51 % of the Elow47 transfor-
mants were found to contain the complete P24 cassette.
For each experiment, ten clones that tested positive in
both PCR reactions were subsequently assayed for P24
expression. Interestingly, none of the analyzed CpP24 and
P24w transformants showed detectable levels of P24
accumulation (see below), neither in the wild-type back-
ground nor in the UVM11 expression strain. Therefore,
these strains were not further analyzed. By contrast, the
fully codon-optimized CrP24 variant conferred strong
mRNA accumulation in all tested transformants of the
expression strain UVM11 and also resulted in
detectable P24 mRNA accumulation in a few transfor-
mants of strain Elow47 (Fig. 2).
To determine the extent to which mRNA accumulation
correlates with protein accumulation, western blot experi-
ments were conducted. To facilitate quantitation of P24
accumulation, a dilution series of recombinantly expressed
P24 was included. No P24 protein could be detected in any
of the CpP24 and P24w transformants (not shown). Three
of the CrP24 transformants in strain Elow47 showed low
levels of P24 protein accumulation (Fig. 3), among them
the two clones that accumulated clearly detectable levels of
the P24 mRNA (cf. Fig. 2b). All transformed clones in
strain UVM11 displayed strong P24 accumulation, with
only moderate variation between transformants (Fig. 3).
Overall, mRNA levels correlated well with protein levels in
that the three UVM11 clones (numbers 5, 6 and 9; cf.
Fig. 2a) that displayed higher mRNA levels than the others
also showed the highest protein accumulation levels. In the
best transformants, P24 accumulated to approximately
0.25 % of the total cellular protein of the alga, as deter-
mined by comparison with a dilution series of purified
recombinant P24 protein (Fig. 3a).
To assess whether or not expression correlated with
transgene copy number in the nuclear genome of the alga,
Southern blot experiments were performed. They revealed
that most of the transformants harbor only a single trans-
gene copy (Fig. 4). Importantly, the three best-performing
transformants (UVM11 transformants 5, 6 and 9) all con-
tain only a single copy of the P24 cassette. Consistent with
previous data (Barahimipour et al. 2015), these data
establish that transgene copy number is not positively
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correlated with expression level. Instead, optimum
expression is achieved when a fully codon-optimized
transgene is expressed in the UVM11 expression strain.
Introduction of variants of the kanamycin resistance
gene nptII into Chlamydomonas cells
Having confirmed the importance of strain background and
codon usage as the two key factors that determine
transgene expression efficiency in the nucleus of Chlamy-
domonas, we reasoned that these principles should also be
applicable to the development of new selectable marker
genes for algal transformation. A number of
selectable marker genes that work in nearly all organisms
are very inefficient or do not work at all in Chlamy-
domonas. The kanamycin resistance gene nptII provides a
case in point. Although being a nearly universally appli-
cable marker for transformation in seed plants, attempts to
Fig. 1 HIV-1 P24 gene variants and physical map of the expression
vector used for algal nuclear transformation. a Relative codon
adaptation (RCA) of the different P24 gene variants compared to the
nuclear genome of Chlamydomonas reinhardtii. Blue bars indicate
the relative adaptation (in %) of each codon in the reading frames of
the three synthetic gene variants. The x-axis indicates the codon
numbers within the gene (cf. Table 1). Variant CrP24 contains the
most frequently used synonymous codon for all amino acids. b GC
content (in %) and its distribution over the reading frames of the three
P24 gene variants. The values were determined in a sliding window of
40 bp. CrP24 is indicated in green, P24w in blue and the chloroplast-
optimized variant CpP24 in red (see color code in panel a). The least
adapted variant (CpP24) has the lowest GC content and the fully
codon-optimized gene version (CrP24) has the highest GC content
(cf. Table 1). c Physical map of the transformation vector used for
expression of the three P24 gene variants in Chlamydomonas
reinhardtii. All variants were cloned into the same vector and are
driven by identical expression elements. The arrows indicate the
binding sites of primer pairs used for PCR analysis of transformed
algal strains. The different P24 coding regions were inserted into an
expression cassette derived from the Chlamydomonas reinhardtii
PSAD locus (Fischer and Rochaix 2001) using the restriction sites
NdeI and EcoRI (PPSAD: PSAD promoter; TPSAD: PSAD terminator).
The paromomycin resistance gene aphVIII serves as
selectable marker and is driven by the fused promoters from the
HSP70A gene (PHSP70) and the RBCS2 gene (PRBCS2) of C. reinhardtii
Table 1 Properties of the different P24 and nptII gene variants used in this study
Gene variant Codon optimization Length (bp) GC content (%) Overall relative
codon adaptation (%)
CpP24 Chloroplast 699 33 21
P24w HIV 699 43 38
CrP24 Nucleus 699 68 100
EcnptII E. coli 792 59 57.8
CrnptII Nucleus 792 73 100
The variants of each transgene have the same size and the identical amino acid sequence but vary in their GC content and codon usage. The
table gives the genome for which the gene variant was optimized, the length of the coding region, the GC content and the RCA relative to the
nuclear genome of Chlamydomonas reinhardtii. See text for details
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develop nptII as a marker for nuclear transformation in
Chlamydomonas have remained largely unsuccessful (Hall
et al. 1993; Bingham et al. 1989).
To test whether nptII can be turned into an efficient
selectable marker gene for Chlamydomonas, we produced
two gene variants and inserted them into identical expres-
sion cassettes for nuclear transformation (Fig. 5). Gene
variant EcnptII represents the original nptII gene from the
E. coli transposable element Tn5. It is relatively GC rich
(59 %) and shows a relative codon adaptation (RCA; Fox
and Erill 2010) of 57.8 %, a value much higher than that of
the CpP24 and the P24w gene versions (cf. Fig. 1;
Table 1). The RCA represents a reference set-based index
in which the codon with the highest frequency (fraction
value) is set to 100 % relative adaptiveness and all other
triplets for the same amino acid are scaled accordingly (by
calculating their frequency of occurrence relative to the
codon with the highest usage).The second nptII variant,
CrnptII, was fully codon optimized for the preferred codon
usage in the nuclear genome of Chlamydomonas rein-
hardtii and has a GC content of 73 % (Fig. 5a, b).
Using glass bead-assisted transformation, the two nptII
variants were introduced into Chlamydomonas expression
strain UVM11 and the wild type-like strain Elow47 (Ne-
upert et al. 2009). Transformed clones were selected on
medium containing a relatively low concentration of
kanamycin (50 lg mL-1) to facilitate the selection of
transformants also with the non-codon-optimized gene
version in strain Elow47. In this way, four sets of trans-
genic algal clones were generated and subsequently com-
pared with respect to their efficiency of expressing the nptII
gene at the mRNA and protein levels.
mRNA and protein accumulation from the two nptII
gene variants in strains Elow47 and UVM11
The four transformation experiments resulted in dramati-
cally different transformation efficiencies, with the wild
type-like strain Elow47 producing very low numbers of
kanamycin-resistant clones, as expected (for quantitative
analysis, see below). From each of the four transformation
experiments, ten kanamycin-resistant clones were ran-
domly picked and assayed for nptII mRNA accumulation
and NptII protein abundance (Fig. 6). It is important to
note that all analyzed transgenic clones were primarily
selected for kanamycin resistance and, therefore, are
expected to express the nptII transgene sufficiently well to
confer resistance to 50 lg mL-1 kanamycin. Thus, differ-
ent from our P24 expression experiments, transgenic clones
that do not express the nptII transgene (as all analyzed
transformants with non-codon optimized P24 genes; see
above) were not recovered.
Analysis of nptII mRNA accumulation revealed that the
nptII transcript was detectable in nearly all selected clones
(Fig. 6a–d), consistent with their kanamycin-resistant
phenotype. However, there were significant differences
between the four sets of transgenic algal clones in the
average expression level of nptII. On average, mRNA
accumulation was highest in UVM11 transformed with
CrnptII, followed by UVM11 transformed with EcnptII,
whereas transcript levels were low in Elow47 transformed
with CrnptII, and lowest in Elow47 transformed with Ec-
nptII (Fig. 6a–d). Expression of the nptII gene in all ran-
domly selected UVM11 transformants confirms that the
kanamycin selection does not produce a significant fraction
of false positive clones (i.e., escapes or spontaneous
Fig. 2 Analysis of CrP24 mRNA accumulation in transformants of
strains UVM11 and Elow47. Ten independent transformants harbor-
ing the complete CrP24 cassette (based on PCR assays; see
‘‘Materials and methods’’ section) were selected randomly for each
strain. 10 lg of total RNA was used for northern blot analysis.
Transformant number five of strain UVM11 was selected as a
standard for relative quantitation, and a dilution series of total RNA
(0.5, 1, 2.5, 5 lg) of this line was loaded in all blots as a positive
control (PC). The untransformed strain was used as negative control
(NC). Asterisks indicate the expected transcript size of 1.1 kb. The
ethidium bromide-stained gel prior to blotting is shown below each
blot and serves as loading control. The whole reading frame of CrP24
was used as hybridization probe. Marker band sizes are given in kb at
the left. Additional transcripts of larger size may originate from
multicopy insertions in tandem and/or from insertion into endogenous
genes in the genome. a Northern blot analysis of UVM11 transfor-
mants. Transformed clone number 1 shows a slightly shorter CrP24
transcript, presumably because of a small deletion or truncation.
b Northern blot analysis of Elow47 transformants
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resistance mutants), a conclusion that is in line with the
absence of kanamycin-resistant colonies from control
plates with untransformed wild-type cells.
When protein accumulation levels were determined by
immunoblot analyses using an anti-NptII antibody, strong
NptII accumulation was seen in UVM11 clones trans-
formed with CrnptII (Fig. 6e). Significantly lower levels of
NptII accumulated in Elow47 transformed with CrnptII and
UVM11 transformed with EcnptII, whereas protein levels
were below the detection limit in most Elow47 clones
transformed with EcnptII (Fig. 6f–h). As observed with
expression of the codon-optimized P24 gene in UVM11,
the NptII protein accumulation levels were nearly uni-
formly high in all tested UVM11-CrnptII clones (Fig. 6e).
In all analyzed UVM11 transformants, the kanamycin
resistance phenotype remained stable over time and culti-
vation cycles in that the clones displayed unaltered drug
resistance after half a year of growth under non-selective
conditions.
Transformation efficiencies with the two nptII gene
variants in strains Elow47 and UVM11
When the transformation experiments with the two nptII
gene variants and the two algal strains were performed, we
noticed that the transformation efficiencies were vastly
different. To verify this observation and quantify the dif-
ferences between constructs and strains, the transformation
experiments were repeated and the transformation fre-
quencies were determined from three sets of transformation
experiments. The data revealed that, indeed, the transfor-
mation efficiencies were greatly different. When strains
UVM11 and Elow47 were transformed with the codon-
optimized CrnptII gene version, the transformation fre-
quency was approximately twice as high with UVM11
upon selection for low levels of kanamycin resistance
(25 lg mL-1). Interestingly, the difference between the
two strains became greater upon selection on higher
antibiotic concentrations, reaching an approximately
Fig. 3 Immunoblot analysis of P24 protein accumulation in strains
UVM11 and Elow47 transformed with the P24 gene variant that was
codon optimized for the Chlamydomonas nuclear genome. The same
ten CrP24 transformants from each strain that had been analyzed by
northern blots (Fig. 2) were tested for P24 accumulation. 40 lg of
total protein from each transformant were separated by SDS-PAGE.
The untransformed strain was used as negative control (NC). A
dilution series of recombinant His-tagged P24 protein (rP24) was
loaded for semiquantitative analysis of P24 accumulation levels. The
small size difference between the recombinant protein and the protein
expressed in algal cells is due to the His-tag. The upper part of the gel
was stained with Coomassie and served as loading control (shown
below each blot). a Immunoblot analysis of UVM11 transformants.
Note that transformed clone number 1 that accumulates a truncated
CrP24 transcript (Fig. 2a), is the only strain that does not accumulate
the P24 protein. The maximum P24 accumulation level is approx-
imately 0.25 % of total cellular protein (strain 6). b Immunoblot
analysis of Elow47 transformants. Clone number 3 shows a larger-
than-expected protein band (of approximately 36 kDa), consistent
with accumulation of a larger mRNA (Fig. 2b). The larger protein
may originate from in-frame fusion with an endogenous gene
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fivefold higher transformation frequency in UVM11 at
200 lg mL-1 kanamycin (Fig. 7a). This observation is
likely explained by the higher nptII expression levels in
UVM11 which allow efficient antibiotic detoxification
even at very high concentrations of kanamycin where most
Elow47 transformants cannot detoxify sufficient amounts
of the drug to survive.
When additionally the two nptII gene variants were
compared, selection for medium-level kanamycin resis-
tance (50 lg mL-1) revealed even larger differences. The
EcnptII gene variant produced only very low numbers of
transformed clones and its transformation frequency in
strain Elow47 was approximately 50-fold lower than that
of CrnptII in strain UVM11 (Fig. 7b).
Antibiotic resistances conferred by nptII
in Chlamydomonas
To test whether NptII expression levels in the two algal
strains correlate with the strength of kanamycin resistance,
series of drop tests on media with different concentrations
of kanamycin (25–200 lg mL-1) were performed.
Although all tested strains were initially obtained in
transformation experiments selecting for resistance to
50 lg mL-1 kanamycin, a number of transformants
obtained with the EcnptII gene and several of the trans-
formants generated in the Elow47 strain grew only poorly
in the presence of 50 lg mL-1 kanamycin, and some of
these even displayed poor growth on 25 lg mL-1 in the
Fig. 4 Southern blot analysis of CrP24 transformants of strains
UVM11 and Elow47. a Physical map of the transformation vector
integrated into the Chlamydomonas nuclear genome. The EcoRI and
EcoRV restriction sites used for RFLP analysis are indicated. The
location of the EcoRV site in the flanking chromosomal DNA is
hypothetical (and variable depending on the integration site of the
transgenes). The hybridization probe (‘Probe’) and the restriction
fragment it detects (‘DNA fragment’) are also indicated. aphVIII:
paromomycin resistance gene (selectable marker); PHSP70: promoter
from the HSP70A gene; PRBCS2: promoter from the RBCS2 gene;
PPSAD: promoter from the PSAD gene; TPSAD: terminator from the
PSAD gene. b Southern blot analysis of ten randomly picked CrP24
transformants of expression strain UVM11 (left panel) and ten
randomly picked transformants of control strain Elow47 (right panel).
Samples of 10 lg total DNA were digested with the restriction
enzymes EcoRI and EcoRV and separated by agarose gel elec-
trophoresis. DNA samples extracted from untransformed strains were
used as negative control (NC) and digested with the same enzymes.
The hybridization probe was generated by labeling a DNA fragment
covering the entire coding region of CrP24. Fragment sizes of the
molecular weight marker (M) are given at the left in kb. Note that the
majority of the transformants harbors a single copy of the CrP24
transgene
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drop tests (e.g., clones Elow47-CrnptII-7; UVM11-Ec-
nptII-1 and Elow47-EcnptII-8; Fig. 8). By contrast, all
transformants with the CrnptII gene in expression strain
UVM11 showed very strong resistance to kanamycin and
all UVM11-CrnptII clones continued to grow under the
highest antibiotic concentration tested (200 lg mL-1).
This resistance level was maintained after half a year of
strain maintenance under non-selective conditions, con-
firming that transgene expression in UVM11 is very
stable (Barahimipour et al. 2015). As expected from the
expression data (Fig. 6), the transgenic clones generated
with EcnptII in Elow47 grew poorest in the drop tests and
all tested transformants died on 200 lg mL-1 kanamycin
(Fig. 8).
The nptII gene encodes the enzyme neomycin phos-
photransferase II, an aminoglycoside 30-phosphotransferase
that inactivates, by covalent modification (phosphoryla-
tion), a range of aminoglycoside antibiotics, including
kanamycin, neomycin, paromomycin and geneticin
(G418). To determine whether the optimized CrnptII gene
in expression strain UVM11 also confers resistance to other
aminoglycoside-type antibiotics, we tested UVM11-
CrnptII transformants on different concentrations of
kanamycin, G418 and paromomycin. As an additional
control, we produced a set of algal transformants with the
paromomycin resistance gene aphVIII (overall RCA
61.76 %, GC content 68.9 %, length 804 bp; Fig. 5c), a
commonly used selectable marker gene in Chlamydomonas
reinhardtii (Sizova et al. 2001). aphVIII encodes an
aminoglycoside phosphotransferase that was shown to not
only detoxify paromomycin, but also confer low-level
resistance to a few other aminoglycoside drugs, including
kanamycin (Sizova et al. 2001). When we compared the
kanamycin resistance levels of UVM11-aphVIII transfor-
mants and UVM11-CrnptII transformants (both selected on
25 lg mL-1 kanamycin), the CrnptII gene turned out to
provide much stronger kanamycin resistance than the aph-
VIII gene (Fig. 9). While all UVM11-CrnptII transformants
grew on 200 lg mL-1 kanamycin, only one UVM11-aph-
VIII clone grew reasonably well on 25 lg mL-1 kanamy-
cin. Unexpectedly, the UVM11-CrnptII transformants also
displayed stronger resistance to paromomycin than the
UVM11-aphVIII transformants (Fig. 9), even though aph-
VIII is the genuine paromomycin resistance gene and the
encoded phosphotransferase exhibits its highest substrate
affinity towards paromomycin. This finding suggests that,
Fig. 5 Codon usage, GC content and physical map of the expression
vector used for transformation of Chlamydomonas with nptII gene
variants and with aphVIII. a Relative codon adaptation (RCA) of the
two nptII gene variants compared to the nuclear genome of
Chlamydomonas. Blue bars indicate the relative adaptation (in %)
of each codon in the reading frames of the two gene variants. The
x-axis indicates the codon numbers within the gene. CrnptII contains
the most frequently used synonymous codon for all amino acids.
b GC content (in %) and its distribution over the reading frames of
the two nptII variants. The values were determined in a sliding
window of 40 bp. CrnptII is indicated in green and the original
(bacterial) EcnptII in blue. The fully codon-optimized CrnptII has a
higher GC content. c Physical map of the transformation vectors used
for expression of the paromomycin resistance gene aphVIII (left
panel) and the two nptII gene variants (right panel) in Chlamy-
domonas. The aphVIII gene is driven by the fused promoters from the
HSP70A gene (PHSP70) and the RBCS2 gene (PRBCS2) of C.
reinhardtii. The nptII coding regions were inserted into an expression
cassette derived from the Chlamydomonas PSAD locus (Fischer and
Rochaix 2001) using the restriction sites NdeI and EcoRI (PPSAD:
PSAD promoter; TPSAD: PSAD terminator)
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even for paromomycin selection, CrnptII outperforms the
conventional resistance gene aphVIII. When the third
aminoglycoside antibiotic, G418 (geneticin), was tested,
none of the UVM11-aphVIII clones displayed any appre-
ciable resistance (not even on the lowest antibiotic con-
centration that is required to suppress growth of wild-type
cells), indicating that G418 is not a substrate of the AphVIII
enzyme, as suspected previously (Sizova et al. 2001). By
contrast, eight out of nine UVM11-CrnptII transformants
showed strong resistance to G418 suggesting that the
CrnptII marker gene can also be combined with G418
selection. Taken together, these data demonstrate that
CrnptII represents a new versatile selectable marker for
Chlamydomonas transformation that facilitates efficient
Fig. 6 Comparison of CrnptII and EcnptII transcript accumulation in
Chlamydomonas strains UVM11 and Elow47 by northern blot
analysis (a–d), and protein accumulation levels conferred by the
two nptII variants as determined by immunoblot analysis (e–h). All
analyzed strains were selected on kanamycin (50 lg mL-1) and,
therefore, are expected to express the nptII marker gene. For the
northern blots (panels a–d), samples of 10 lg total RNA were
electrophoretically separated in denaturing 1.2 % agarose gels. The
gel blots were hybridized to a radiolabeled probe comprising a 1:1
mixture of the complete coding regions of both nptII variants. RNA
samples isolated from the corresponding untransformed strains were
used as negative control (NC). A dilution series (0.5, 1.0, 2.5 and
5.0 lg RNA) of an NptII-expressing algal clone (CrnptII transformant
number 3 in strain UVM11) was loaded onto each gel as a positive
control (PC) to facilitate comparison between blots. The band
representing the 25S rRNA of the cytosolic 80S ribosome in the
ethidium bromide-stained gel prior to blotting is shown below each
blot as a loading control. Sizes of RNA marker bands are indicated in
the right of each blot (in kb). The size of the nptII transcript is
approximately 1.2 kb. For the immunoblots (panels e–h), samples of
40 lg total cellular protein were separated by SDS-PAGE and the
same transformed strains were analyzed as in panel (a-d). A dilution
series of recombinant NptII (rNptII) was loaded to facilitate
semiquantitative analysis and comparison between blots. The size
of the untagged protein expressed in Chlamydomonas is *29 kDa,
the slightly larger size of the rNptII is due to its His-tag. Protein
samples of the untransformed strains were loaded as negative controls
(NC). As a control for equal loading, the Coomassie-stained upper
part of the gel is shown below each blot. a nptII mRNA accumulation
in ten independent transgenic clones of expression strain UVM11
transformed with gene variant CrnptII. b nptII mRNA accumulation
in ten independent clones of strain Elow47 transformed with gene
variant CrnptII. c nptII mRNA accumulation in ten independent
transgenic clones of expression strain UVM11 transformed with the
EcnptII gene variant. d nptII mRNA accumulation in ten independent
transgenic clones of strain Elow47 transformed with the EcnptII gene
variant. e NptII protein accumulation in ten independent transgenic
clones of expression strain UVM11 transformed with gene variant
CrnptII. f NptII protein accumulation in ten independent clones of
strain Elow47 transformed with gene variant CrnptII. g NptII protein
accumulation in ten independent transgenic clones of expression
strain UVM11 transformed with the EcnptII gene variant. Note that
strains 4 and 5 show above-background expression of NptII, whereas
in all other transformed clones, the signal is not stronger than that of
the cross-reacting band of similar size in the NC. h NptII protein
accumulation in ten independent transgenic clones of strain Elow47
transformed with the EcnptII gene variant
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selection of transgenic algal clones and confers strong
resistance to at least three different aminoglycoside
antibiotics: kanamycin, paromomycin and G418.
Discussion
In this study, we have investigated two transgenes as case
studies for the expression of biotechnologically relevant
genes from the nuclear genome of the model green alga
Chlamydomonas reinhardtii. We selected a protein antigen,
the HIV capsid protein P24, and an antibiotic resistance
gene (nptII) that works as an efficient selectable marker in
many prokaryotic and eukaryotic systems, but does not
work well in Chlamydomonas (Hall et al. 1993; Bingham
et al. 1989). As previous work had suggested that (i) codon
usage is a major determinant of expression efficiency at the
level of the gene sequence (Barahimipour et al. 2015), and
(ii) greatly improved expression of fluorescent reporter
proteins can be achieved in the UVM4 and UVM11 strains
(Neupert et al. 2009; Karcher et al. 2009; Barahimipour
et al. 2015), we comparatively analyzed codon-optimized
and non-optimized gene variants (encoding the identical
amino acid sequence), and tested them in both a UVM
expression strain and a wild type-like control strain. Our
data demonstrate that, for both transgenes, maximum
expression levels are obtained when combining the fully
codon-optimized coding region with the UVM11 algal
expression strain.
Compared to the non-optimized P24 gene versions
CpP24 and P24w, the non-codon-optimized nptII gene
(EcnptII) performed reasonably well in that, especially in
the UVM11 background, it gave rise to detectable gene
expression at both the mRNA and the protein levels and
also conferred substantial kanamycin resistance (Figs. 6, 7,
8). This is most likely due to the codon usage of the E. coli
nptII gene (EcnptII) being closer to the codon usage in the
Chlamydomonas nuclear genome than codon usage and GC
content of the two non-optimized P24 gene versions
(Figs. 1a, b, 5a, b). The unsuccessful expression of the
CpP24 and P24w variants indicates that attempts to express
AT-rich transgenes with low relative codon adaptation
(RCA) are unlikely to be successful in Chlamydomonas.
As noted previously for the YFP reporter gene (Bar-
ahimipour et al. 2015), mRNA accumulation and protein
abundance in the transgenic algal strains are well correlated
(e.g., Figs. 2, 3). As transcription of all gene variants is
controlled by exactly the same expression cassette and,
therefore, transcription rates are expected to be similar, this
correlation may suggest that the high translation rates
mediated by the fully codon-optimized synthetic gene
versions promote mRNA stability. We, therefore, hypoth-
esize, that the difference in mRNA accumulation observed
for the different gene variants is due to the different ribo-
some coverage of the transcripts. This conclusion is in
agreement with recent studies in yeast (Saccharomyces
cerevisiae) that revealed a strong impact of translation rates
on mRNA stability (Presnyak et al. 2015). A possible
mechanistic explanation could be that, similar to the situ-
ation in bacteria, translating ribosomes protect the mRNA
from endoribonucleolytic attack by RNA-degrading
enzymes (Braun et al. 1998; Sunohara et al. 2004; Deana
and Belasco 2005).
Fig. 7 Transformation efficiencies obtained with the two nptII gene
variants in Chlamydomonas strains UVM11 and Elow47. a Analysis
of transformation efficiencies obtained with CrnptII in expression
strain UVM11 and the corresponding wild type-like strain Elow47 at
different concentrations of kanamycin. The strains were transformed
with the CrnptII cassette and selection was performed on media
containing different concentrations of kanamycin (25, 50, 100 and
200 lg mL-1). The number of kanamycin-resistant colonies was
averaged from three independent transformation experiments. Error
bars indicate the standard deviation. b Comparison of transformation
efficiencies obtained with the two nptII variants in strains UVM11
and Elow47. Algal cells were transformed with either the CrnptII or
the EcnptII cassette and selected on medium containing 50 lg mL-1
kanamycin. The number of resistant colonies was averaged from three
independent transformation experiments (scored 6 days after trans-
formation). Error bars indicate the standard deviation
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In contrast to codon usage and strain background,
transgene copy number has no pronounced influence on the
attainable expression level (Fig. 4). Thus, the two simple
recommendations for optimized transgene expression that
can be deduced from this study and previous work (Bar-
ahimipour et al. 2015) are to (i) use synthetic genes with
fully optimized codon usage for the Chlamydomonas
nuclear genome, and (ii) introduce the transgenes into a
UVM expression strain (Neupert et al. 2009). It is also
important to note that, with this strategy, the success rate
with transgene expression is close to 100 % in that all
transformed UVM11 clones that contained the complete
CrP24 cassette also expressed it to high levels, with only
moderate variation in expression strength between inde-
pendent transformants (Fig. 3). A similar observation was
made previously when fluorescent reporter genes were
expressed in UVM strains (Neupert et al. 2009; Bar-
ahimipour et al. 2015).
Genetic engineering technologies are critically depen-
dent on efficient selection systems for transgenic cells.
Although by now, a number of useable selectable marker
genes have been established for Chlamydomonas (re-
viewed, e.g., in Weeks 1992; Neupert et al. 2012; Jinkerson
and Jonikas 2015; Mussgnug 2015), some of the most
efficient markers in other organisms do not work well in
Chlamydomonas. In this work, we have tested the idea that
this is not due to biochemical or physiological peculiarities
of Chlamydomonas cells (e.g., drug uptake or extrusion
problems, rapid drug metabolization or sequestration), but
rather to the inefficiency with which foreign genes are
expressed in the nucleus of the alga. Taking one of the
most widely deployed selectable marker genes, the kana-
mycin resistance gene nptII, as an example, we have shown
that this is indeed the case. The codon-optimized CrnptII
gene variant expressed in expression strain UVM11
allowed efficient selection of transgenic algal clones on
kanamycin concentrations that were similarly high (50-
75 lg/mL) or even substantially higher than those con-
ventionally used for the selection of transgenic plants
(Figs. 7 and 8). Our results explains why, previously, nptII
could not be established as a selectable marker gene for
Chlamydomonas transformation (Hall et al., 1993; Bing-
ham et al., 1989). The reason why we obtained a few
transformants also with EcnptII in the wild type-like strain
Elow47 (1, 2 and 7 clones, respectively, in the three
independent transformation experiments) may be that we
used a stronger promoter to drive the nptII gene. The PSAD
promoter used here controls the expression of an abundant
thylakoid protein in the chloroplast (the D subunit of
photosystem I) and was shown to be an excellent promoter
Fig. 8 Kanamycin resistance assays with CrnptII and EcnptII
transformants of strains UVM11 and Elow47. The ten transformants
per strain and gene variant that had been analyzed with respect to
mRNA and protein accumulation levels were assayed for their
antibiotic resistance by drop tests with three different cell concen-
trations (7 ll of cell suspensions with 107, 106 and 105 cells mL-1)
on agar plates containing different concentrations of kanamycin (0,
25, 50, 75, 100 and 200 lg mL-1). Untransformed UVM11 and
Elow47 were used as negative controls. Note that all transformed
clones shown here were initially selected on kanamycin
(50 lg mL-1) and, therefore, display some kanamycin resistance.
However, on average, CrnptII transformants are more resistant to the
antibiotic than EcnptII transformants, and UVM11 transformants
tolerate higher kanamycin concentrations than Elow47 transformants
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for transgene expression in Chlamydomonas (Fischer and
Rochaix 2001).
In our hands, the optimized nptII used as
selectable marker for transformation of the expression
strain is similarly efficient as other antibiotic resistance
markers commonly employed for transformation of Ch-
lamydomonas, such as hygromycin or paromomycin
resistance genes (Berthold et al. 2002; Sizova et al. 2001).
Thus, our work provides a new efficient selectable marker
gene for Chlamydomonas transformation and also suggests
a simple strategy for developing additional markers for
selection of transgenic algal cells.
As a result of our efforts to optimize expression of the
HIV antigen P24 in Chlamydomonas, recombinant protein
accumulation levels of up to 0.25 % of the total cellular
protein were reached (Fig. 3). Previous attempts to
express P24 from the tobacco nuclear genome led to
accumulation levels of up to 0.35 % of the plant’s total
soluble protein (Zhang et al. 2002). Considering that a
value expressed as total soluble protein is probably
approximately one-third higher than the corresponding
value expressed as total cellular protein, the expression
levels achieved in tobacco and Chlamydomonas are
remarkably similar. This suggests that the combination of
codon-optimized synthetic genes with our expressions
strains largely overcomes the transgene expression prob-
lem in Chlamydomonas and makes the alga competitive
with seed plants as an expression host for recombinant
proteins. Although several other algae (e.g., some Chlor-
ella species) can be grown to higher cell densities than
Chlamydomonas, which is a potential advantage for
applications requiring high biomass production, the
molecular toolboxes currently available for other algal
species do not even come close to that available for Ch-
lamydomonas. Also, for many applications, such as the
production of high-value biopharmaceuticals, the costs of
biomass production are negligible compared the costs for
downstream processing and purification which, to a large
extent, are determined by the attainable protein accumu-
lation level in the cell (Ma et al., 2005). Finally, we
expect that the tools and guidelines for optimized trans-
gene expression, as developed for Chlamydomonas, will
also be applicable to other algal species.
In summary, the application of the optimization strate-
gies described here will considerably expand the range of
biotechnological applications that can be pursued in Ch-
lamydomonas and other algae, and likely will facilitate new
approaches in metabolic pathway engineering and molec-
ular farming (Scaife et al. 2015).
Fig. 9 Comparison of the detoxification efficiency of aphVIII and
CrnptII for different antibiotics. Nine randomly selected transfor-
mants of UVM11 with either aphVIII or CrnptII (both initially
selected on 25 lg mL-1 kanamycin; Sizova et al. 2001) were
assayed. The untransformed UVM11 strain was used as negative
control (NC). Drop tests were performed using three different cell
concentrations (7 ll of cell suspensions containing 107, 106 and
105 cells mL-1) on agar plates containing different concentrations of
paromomycin (5, 10, 25 and 50 lg mL-1), kanamycin (25, 50, 100
and 200 lg mL-1) or G418 (2.5, 5, 10 and 25 lg mL-1). Pho-
tographs were taken after 12 days. Note that, although initially
selected on medium containing 25 lg mL-1 kanamycin, some
aphVIII transformants do not grow on kanamycin and paromomycin.
This could be due to silencing of the (non-codon-optimized) aphVIII
transgene during strain maintenance under non-selective conditions
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